*DXS INTERNATIONAL PLC*
*(AQSE: DXSP)*
*Notification of Director / PDMR Dealing*
*DXS INTERNATIONAL PLC*
The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 30 October 2024 Mr Bob Sutcliffe, the Chairman, purchased a total of 50,000 Ordinary Shares in the Company at a price of 1.0p per share. Further, today 31 October 2024, Mr Bob Sutcliffe purchased a total of 133,333 Ordinary Shares in the Company at a price of 1.5p per share
Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,116,719 Ordinary Shares representing 1.74% of the issued share capital of the Company.
*1*
*Details of the person discharging managerial responsibilities / person closely associated*
a)
Name
Mr. Robert Sutcliffe
*2* *Reason for the notification*
a)
Position/status
Chairman
b)
Initial notification /Amendment
Initial
*3*
*Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor*
a)
Name
DXS INTERNATIONAL PLC
b)
LEI
2138001R1KEUWTXEVJ44
*4*
*Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted*
a)
Description of the financial instrument, type of instrument Ordinary Shares of 0.33p each
Identification code ISIN GB00B2Q6HZ92
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s) Price(s) Volume(s) 1.0p 50,000 1.5p 133,333
d)
Aggregated information
- Aggregated volume
- Price
e)
Date of the transaction
30 October 2024 and 31 October 2024
f)
Place of the transaction
Aquis Stock Exchange
The Directors of DXS International plc accept responsibility for this announcement.
*Contacts:*
David Immelman
DXS International plc
www.dxs-systems.com
01252 719800
AQSE Corporate Broker and Corporate Advisor
Hybridan LLP
Claire Louise Noyce 020 3764 2341
Notes to Editors
*About DXS:*
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.
Trusted News Discovery Since 2008
{{/content}}
Director/PDMR Shareholding
Credit: GlobeNewswire- Published 2 weeks ago
You are here
Related news from verified sources
State-owned UCO Bank plans to raise up to Rs 2,000 crore through a share sale via qualified institutional placement in the December quarter. This move aims to...
on October 19, 2024 • IndiaTimes
The market watchdog has alleged wrongful categorisation of certain investors as public shareholders under its minimum shareholding norms.
3 weeks ago • Zee News
Lodha Group is transferring a substantial shareholding in Macrotech Developers to Lodha Philanthropy Foundation with an initial Rs 20,000 crore. This move will...
2 weeks ago • IndiaTimes